Anavex Life Sciences Corp (AVXL) showcases strong financial health and advances in Alzheimer's and schizophrenia treatments, ...

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 Second Quarter Conference Call. My name is Clint ...

NEW YORK (AP) — NEW YORK (AP) — Anavex Life Sciences Corp. (AVXL) on Tuesday reported a loss of $11.2 million in its fiscal second quarter. On a per-share basis, the New York-based company said it had ...

Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage ...

H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ and H.C. Wainwright 6th Annual Neuro Perspectives ConferenceNEW YORK, M ...

We recently published a list of 10 Low Risk High Reward Stocks Set to Triple by 2030. In this article, we are going to take a ...

Anavex Life Sciences (AVXL) is scheduled to announce Q2 earnings results on Tuesday, May 13th, before market open. The consensus EPS Estimate is -$0.15. Over th ...

Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...